ACRV – acrivon therapeutics, inc. (US:NASDAQ)
Stock Stats
News
H.C. Wainwright Initiates Coverage on Acrivon Therapeutics (ACRV) With “Buy” Rating and $19 PT [Yahoo! Finance]
Acrivon Therapeutics (NASDAQ:ACRV) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
Acrivon Therapeutics (NASDAQ:ACRV) was upgraded by analysts at Wall Stre
Acrivon Therapeutics (NASDAQ:ACRV) was upgraded by analysts at Wall Stre
Acrivon Therapeutics Highlights its Powerful Generative Phosphoproteomics AP3 Platform with Compelling Preclinical Data for ACR-2316 with Three Presentations at the Upcoming AACR-NCI-EORTC International Conference [Yahoo! Finance]
Form 4 Acrivon Therapeutics, For: Nov 21 Filed by: Blume-Jensen Peter
Form SCHEDULE 13G Acrivon Therapeutics, Filed by: CITADEL ADVISORS LLC
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Peterson Katharine
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Miller Mary
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Gamelin Erick
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.